DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Bokemeyer C, Bondarenko I, Makhson A et al.
Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study.

Journal of Clinical Oncology 2007; ASCO Annual Meeting Proceedings Part I 2007
25 (Suppl. 18) 4035

Download Bibliographical Data

Search in: